Develops and commercializes proprietary pharmaceutical products for the treatment of eye diseases, as well as dermatological and urological conditions. By utilizing two proprietary technology platforms, photodynamic therapy (PDT) and Atrigel® drug delivery system, the company develops commercial products such as Visudyne® for the treatment of the eye disease known as wet age-related macular degeneration (wet AMD), and Eligard® for the treatment of prostate cancer.